Enhanced antibody half-life improves in vivo activity

Jonathan Zalevsky(Xencor (United States)), Aaron K. Chamberlain(Xencor (United States)), Holly M. Horton(Xencor (United States)), Sher Karki(Xencor (United States)), Irene Leung(Xencor (United States)), Thomas J. Sproule(Jackson Laboratory), Greg A. Lazar(Xencor (United States)), Derry C. Roopenian(Jackson Laboratory), John R. Desjarlais(Xencor (United States))
Nature Biotechnology
January 17, 2010
10.1038/nbt.1601
Cited by 641Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis